3rd World Congress on
Pharmacovigilance & Drug Safety

Dr. Francis Paul Jagolino is a Physiology, Biochemistry and Pharmacology Professor in various medical schools in Manila and has been in the academe for 6 years. He completed his Doctor of Medicine degree at Emilio Aguinaldo College – School of Medicine and Master in Management, Major in Health Administration at Philippine Christian University. He is currently the Head of the Department of Physiology at the Lyceum of the Philippines University – St. Cabrini School of Health Sciences. Dr. Jagolino is also a Fellow of the Physiology Society of the Philippines and former President of the Philippine Society of General Physicians. Aside from teaching, Dr. Jagolino is an active General Practitioner who has been assigned to hospitals at the furthest provinces of the Philippines. It was during this time when he gained a keen interest in observing many cases of antibiotic resistance due to rampant and unsupervised use of common antibiotics by the public. He made it a point to launch Public Health Campaigns to educate patients and the populations in those provinces on the dangers posed by antibiotic resistance. Dr. Jagolino is set to publish a research on this topic within the next few years. Dr. Jagolino is also a sought after international seminar speaker having spoken on topics relating to Healthcare, Psychology, Pharmacology, Herbal Medicines and Supplementation and Skin Care as well as topics on Corporate Leadership and Management in Singapore, Malaysia, Dubai, Oman and Qatar. He has also been a guest in some Local Television Talk Shows to share his healthcare knowledge to the general public.

Health Administration

Dr Hamid Qoura, is Graduated from Kasr El-Aini medical school, (Faculty of medicine Cairo University) 1983. Finished his Master degree from the same college. Had MRCS from Ireland and FEBPS from Glasgow. Had a diploma in laparoscopic surgery from Strasbourg, France. He is working at present as a consultant and HOD of Pediatric Surgery in Nizwa Hospital, Oman. He published more than 10 papers in reputed Journals. Has special interest in laparoscopic surgery. He is the first one did real single port laparoscopic umbilical hernia, epigastric hernia and divarication of recti repair. And can do through the same port inguinal hernias of the same patient. He has a channel on YouTube displaying on it some of the difficult and interesting laparoscopic surgeries he did. Youtube Channel: qora21 Link: https://www.youtube.com/user/qora21

Laparoscopic surgery

Danielle IWANDZA is the founder and CEO of PharmaCqARE, a cabinet providing drug-related counsel, training and services for pharmaceutical companies, authorities and healthcare professionals; she has 21 years of experience in the European pharmaceutical industry. She has been an independent pharmacovigilance senior consultant for 7 years, providing her services to medium sized and big pharma companies in France,Germany, Switzerland and The Netherlands. Prior to that, she had growing pharmacovigilance responsibilities and has been head of pharmacovigilance in France for a big pharma company and pharmacovigilance head & EU-QPPV for a hospital generic company. She was previously physician clinical research for 3 years and prior to that had been a medical practitioner in hospitals and clinics in the south of France. She graduated in the specialty of dermatology from the University of Montpellier in France. She also holds a clinical research degree from Sup’Santé school in Paris and a pharmacoepidemiology degree from the Bordeaux school of Pharmacy

Pharmacovigilance & Clinical Trials

Giulio Tarro graduated from Medicine School, Naples University (1962), Italy. Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus (2006). Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President, Foundation de Beaumont Bonelli for Cancer Research. His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor-associated antigen, 55 kilodalton protein overexpressed in lung tumors, and other epithelial adenocarcinomas.

Virology, Oncology, Immunology and Microbiology

Dr.Jorge I. González Borroto is a Toxicologist with more than 15 years of expertise in the field of Toxicology, Pharmacovigilance, and Drug safety assessment. He has worked for many Pharma Companies and Contract Research Organizations. He is currently working as a Senior Toxicologist, involved in Pharmacovigilance to support the efficacy, safety and well-use of medicines, in Ferrer Internacional, Barcelona, Spain. He is also the director of in vitro and in vivo toxicological studies in drug development and drug-candidate selection. He has more than 10 years of Experience in toxicological data interpretation, preparation of nonclinical toxicology-safety report, reviews and summaries of safety of new drugs to support clinical studies, predictive toxicology, Set up and validation of novel test and cell-based assays in drug discovery. He is also the Reviewer of the Journals of Toxicology and Editorial Board Member of several scientific journals and Organizing Committee Member of several Scientific events. He has involved in the European Commission as an expert for the Sixth and Seventh Framework Programme in the area Preclinical Toxicology and Mutagenesis as well.

Toxicology, Safety Assessment, Pharmacovigilance, Quality Control, Clinical Research, Safety Pharmacology, Toxicokinetic, Bioanalysis, Drug Development

Keith J. Simons joined the Faculty of Pharmacy, the University of Manitoba in 1975 as an Assistant Professor. He was promoted to Full Professor in 1986, with adjunct appointments in the Faculty of Science and the Faculty of Medicine. He was Head of the Division of Pharmaceutical Sciences from 1994-2004, and Associate Dean, Research from 2004 to 2009. During a career spanning more than three decades, he developed and taught undergraduate and graduate courses in physical pharmacy, pharmaceutics, dispensing and non-prescription drugs, and pharmacokinetics. He has contributed to the education of more than 1,200 pharmacists, most of who practiced or are currently practicing in the province of Manitoba. He has mentored many MSc and PhD students. His research work resulted in more than 360 publications During his long career, Dr. Simons served on and chaired most of the Faculty of Pharmacy standing committees, most recently various Faculty of Graduate Studies committees. He is an active member of a number of pharmaceutical and medical associations in Canada and the United States. He served as a Council Member (1976-1985) and as President (1986-1987) of the Association of Faculties of Pharmacy of Canada, as an examiner (1976-1988) on the Pharmacy Examining Board of Canada, and as the elected representative of the academic pharmacists on the Canadian Pharmacists Association Board of Directors (1991-2002). In November 2013 he was awarded the first Leslie F. Buggey Professorship in the Faculty of Pharmacy.

Pharmaceutics, Pharmacokinetics and Pharmacodynamics, Allergy & Clinical Immunology, Clinical Research

Dr. Carolle-Laure KPOUMIE has worked as pediatric assistant physician in pediatric’s department of faculty of medicine in Cameroon, as clinical researcher methodology, scientific writing, public health, oncology, internal medicine and continued her career in pharmaceutical industries in France. She participates in many congress with studies made in hospitals on relevant cases in the framework Studies and clinical research. She became head of department, director, head of district where she continued her research, writing of treatment protocols in different departments for common pathologies encountered in her context, managing Epidemic crisis such as cholera, meningitis, avian influenza, yellow fever and organizes campaigns on infectious diseases ,HIV, cardiovascular diseases, family planning, research on severe malaria, malnutrition in Children and participates in studies on neonatal mortality in underdeveloped countries. She work on ADR in hospital following drug administration, pharmacovigilance, vaccinovigilance, biovigilance, materiovigilance in underdeveloped countries, articles, medical information and therapeutic safety, clinical trials, Post-marketing, and other’s studies.

Clinical Reserach, Pharmacology & Toxicology, Pharmacovigilance,Internal medecine, Rare Deseases, Oncology, Haematology,Endocrinology, Antiviral therapy and Neuropsychiatry